SEC Filing Update: #ARWR Arrowhead Pharmaceuticals, Inc. : $85.59

Sector: Healthcare | YTD: 🔼+ 26.20% The SEC disclosed Today (14-AUG-2026) that AVORO CAPITAL ADVISORS LLC has INCREASED #ARWR Shares by 21.73% 🟢 * Previous Holdings: 11.36M Shares * Current Holdings: 13.82M Shares * Increase+2.47M * Increased(%)+21.73% * Ownership: 9.64% * Estimated Investment Value: $215.12M https://www.thinksabio.com/reports/isr/ARWR Institutional ownership in #ARWR has been steadily rising over the past 7 quarters in Shares: Q3 2024: 95.80M Q4 2024: 99.82M Q1 2025: 103.19M Q2 2025: 105.72M Q3 2025: 110.99M Q4 2025: 115.99M Q1 2026: 120.77M The quarterly average prices of #ARWR: Q3 2025: $21.98 Q4 2025: $48.68 Q1 2026: $63.30